OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 75 filers reported holding OCULAR THERAPEUTIX INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,420,000 | +420.1% | 142,000 | +638.9% | 0.19% | +405.3% |
| Q2 2021 | $273,000 | +79.6% | 19,217 | +107.8% | 0.04% | +26.7% |
| Q1 2021 | $152,000 | -42.0% | 9,250 | -75.7% | 0.03% | +200.0% |
| Q3 2016 | $262,000 | -68.9% | 38,100 | -57.7% | 0.01% | -78.3% |
| Q4 2015 | $843,000 | -43.0% | 90,000 | -14.4% | 0.05% | -24.6% |
| Q3 2015 | $1,479,000 | -29.7% | 105,190 | +5.2% | 0.06% | -20.8% |
| Q2 2015 | $2,103,000 | -9.6% | 100,000 | +1.1% | 0.08% | +4.1% |
| Q4 2014 | $2,327,000 | -47.7% | 98,951 | -66.7% | 0.07% | -56.7% |
| Q3 2014 | $4,448,000 | – | 297,107 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |